ALFA Filings
Every announcement, straight from the exchange
Every Evoq Remedies financial results announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements with these filters
Evoq Remedies Limited reported audited financial results for the year ended March 31, 2026. The auditor issued a qualified opinion citing material uncertainty regarding going concern.
Evoq Remedies Ltd reported a net loss of ₹0.3 Cr for H2 FY26.
Evoq Remedies Limited reported annual revenue of ₹26.76 Crore for FY2026. The board also appointed M/s. Jay Pandya & Associates as secretarial auditors for FY2025-26.